No well-controlled trial shows that cannabis treats ADHD. The FDA has not approved any cannabis product for ADHD. Standard care uses approved medicines and behavioral therapy.
What the research shows
Trials on cannabis for ADHD are small and few. Reviews find no reliable data that cannabis reduces ADHD symptoms. Some studies link cannabis use to worse attention, worse memory, and worse school or work outcomes in people with ADHD.
People with ADHD report using cannabis for sleep, anxiety, or focus. Reports are not proof of treatment effect. Placebo effects and expectation can shape self-ratings.
Standard ADHD treatment
FDA-approved ADHD medicines include stimulants such as methylphenidate and amphetamines. Non-stimulant options include atomoxetine, viloxazine, guanfacine, and clonidine. Behavioral therapy and skills training also have evidence.
CBD and THC
CBD is not a proven ADHD treatment. THC can impair attention and memory in the short term. Cannabis products vary in THC and CBD content. Labels may not match actual content.
Risks and interactions
Cannabis can cause anxiety, impaired coordination, and faster heart rate. Regular use can lead to dependence. Cannabis may interact with ADHD medicines and other drugs. Driving after use is unsafe.
Legal and clinical status
Cannabis remains illegal under US federal law. State laws differ. The FDA has not approved cannabis for ADHD. Clinicians do not prescribe cannabis as ADHD medicine.
What to ask a clinician
Ask about approved ADHD medicines, therapy, sleep habits, and side effects. Tell your clinician about any cannabis use. Ask about drug interactions and state law.